Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Dpm-1001
2. 1471172-27-6
3. Methyl (4r)-4-[(3r,5r,7r,8r,9s,10s,13r,14s,17r)-7-hydroxy-10,13-dimethyl-3-[4-(pyridin-2-ylmethylamino)butylamino]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoate
4. Hy-121515
5. Cs-0082256
| Molecular Weight | 567.8 g/mol |
|---|---|
| Molecular Formula | C35H57N3O3 |
| XLogP3 | 6.2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 13 |
| Exact Mass | 567.43999269 g/mol |
| Monoisotopic Mass | 567.43999269 g/mol |
| Topological Polar Surface Area | 83.5 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 855 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
74
PharmaCompass offers a list of DPM-1001 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right DPM-1001 manufacturer or DPM-1001 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred DPM-1001 manufacturer or DPM-1001 supplier.
PharmaCompass also assists you with knowing the DPM-1001 API Price utilized in the formulation of products. DPM-1001 API Price is not always fixed or binding as the DPM-1001 Price is obtained through a variety of data sources. The DPM-1001 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DPM-1001 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DPM-1001, including repackagers and relabelers. The FDA regulates DPM-1001 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DPM-1001 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A DPM-1001 supplier is an individual or a company that provides DPM-1001 active pharmaceutical ingredient (API) or DPM-1001 finished formulations upon request. The DPM-1001 suppliers may include DPM-1001 API manufacturers, exporters, distributors and traders.
DPM-1001 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DPM-1001 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DPM-1001 GMP manufacturer or DPM-1001 GMP API supplier for your needs.
A DPM-1001 CoA (Certificate of Analysis) is a formal document that attests to DPM-1001's compliance with DPM-1001 specifications and serves as a tool for batch-level quality control.
DPM-1001 CoA mostly includes findings from lab analyses of a specific batch. For each DPM-1001 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DPM-1001 may be tested according to a variety of international standards, such as European Pharmacopoeia (DPM-1001 EP), DPM-1001 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DPM-1001 USP).
